Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 65.65
-1.60 (-2.38%)
Nov 17, 2025, 2:14 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 40.03 billion as of November 14, 2025. Its market cap has increased by 35.57% in one year.
Market Cap
40.03B
Enterprise Value
36.86B
Revenue
3.85B
Ranking
n/a
PE Ratio
42.73
Stock Price
65.65
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 40.03B, an increase of 9.45%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 40.03B | 52.01% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 417.34B |
| WuXi AppTec | 285.68B |
| Shenzhen Mindray Bio-Medical Electronics | 251.81B |
| Sichuan Biokin Pharmaceutical | 153.43B |
| Aier Eye Hospital Group | 114.43B |
| Shanghai United Imaging Healthcare | 112.24B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.07B |
| Yunnan Baiyao Group Co.,Ltd | 101.81B |